Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Girndt

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Der Internist|July 2, 2005
[Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy]S Nitschmann, M Girndt, H Köhler
Der Urologe. Ausg. A|December 20, 2019
[Waiting list management]U Pein, A Fritz, M Girndt
Der Internist|February 18, 2011
[Optimal point of time for initiation of dialysis. IDEAL Study (Initiating Dialysis EArly and Late)]S Nitschmann, S Markau, M Girndt
Deutsche Medizinische Wochenschrift (1946)|May 28, 1993
[The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect]H Köhler, M Girndt, H Dumann, et al.
Journal of the American Society of Nephrology : JASN|September 4, 1998
Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell levelM Girndt, U Sester, H Kaul, et al.
Deutsche Medizinische Wochenschrift (1946)|May 21, 1993
[The immune defect in kidney failure. I. The clinical manifestations]H Köhler, M Girndt, H Dumann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1999
Impaired cellular immune function in patients with end-stage renal failureM Girndt, U Sester, M Sester, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 31, 2000
Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal diseaseH Kaul, M Girndt, U Sester, et al.
Kidney International|March 22, 2001
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defectM Girndt, M Sester, U Sester, et al.
Der Urologe. Ausg. A|October 31, 1998
[Nephrotic syndrome. Development, complications and treatment]U Sester, M Girndt, H Kaul, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Der Internist|July 2, 2005
[Detail study of angiotensin-receptor blockade versus ACE-inhibition in type 2 diabetes with nephropathy]S Nitschmann, M Girndt, H Köhler
Der Urologe. Ausg. A|December 20, 2019
[Waiting list management]U Pein, A Fritz, M Girndt
Der Internist|February 18, 2011
[Optimal point of time for initiation of dialysis. IDEAL Study (Initiating Dialysis EArly and Late)]S Nitschmann, S Markau, M Girndt
Deutsche Medizinische Wochenschrift (1946)|May 28, 1993
[The immune defect in kidney failure. II. The mechanisms of the "uremic" immune defect]H Köhler, M Girndt, H Dumann, et al.
Journal of the American Society of Nephrology : JASN|September 4, 1998
Production of proinflammatory and regulatory monokines in hemodialysis patients shown at a single-cell levelM Girndt, U Sester, H Kaul, et al.
Deutsche Medizinische Wochenschrift (1946)|May 21, 1993
[The immune defect in kidney failure. I. The clinical manifestations]H Köhler, M Girndt, H Dumann, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 26, 1999
Impaired cellular immune function in patients with end-stage renal failureM Girndt, U Sester, M Sester, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 31, 2000
Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal diseaseH Kaul, M Girndt, U Sester, et al.
Kidney International|March 22, 2001
Defective expression of B7-2 (CD86) on monocytes of dialysis patients correlates to the uremia-associated immune defectM Girndt, M Sester, U Sester, et al.
Der Urologe. Ausg. A|October 31, 1998
[Nephrotic syndrome. Development, complications and treatment]U Sester, M Girndt, H Kaul, et al.
Pageof 4